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Upon engagement of the T cell receptor with an anti-
gen-presenting cell, LCK initiates TCR signaling by
phosphorylating its activation motifs. However, the
mechanism of LCK activation specifically at the im-
mune synapse is a major question. We show that
phosphorylation of the LCK activating Y394, despite
modestly increasing its catalytic rate, dramatically
focuses LCK localization to the immune synapse.
We describe a trafficking mechanism whereby
UNC119A extracts membrane-bound LCK by
sequestering the hydrophobic myristoyl group, fol-
lowed by release at the target membrane under the
control of the ciliary ARL3/ARL13B. The UNC119A
N terminus acts as a ‘‘regulatory arm’’ by binding
the LCK kinase domain, an interaction inhibited by
LCK Y394 phosphorylation, thus together with the
ARL3/ARL13B machinery ensuring immune synapse
focusing of active LCK. We propose that the ciliary
machinery has been repurposed by T cells to
generate and maintain polarized segregation of sig-
nals such as activated LCK at the immune synapse.
INTRODUCTION
T cell receptor (TCR) signaling takes place upon the interaction of
the TCR with its cognate peptide-major histocompatibility com-
plex (pMHC) on the antigen-presenting cell (APC). An initial event
in TCR signaling is the phosphorylation of immunoreceptor tyro-
sine-based activation motifs (ITAMs) on the intracellular tails of
the TCR by the lymphocyte-specific tyrosine protein kinase,
LCK. LCK activity, similar to that of other SRC family kinases
(SFKs), is regulated by the phosphorylation of two key tyrosine
residues. Phosphorylation of tyrosine 394 in the activation loop
increases its kinase activity, whereas phosphorylation of tyrosine
505 downregulates LCK activity (Boggon and Eck, 2004). There
are four populations of LCK in T cells: active (pY394), inactive
(pY505), primed (no phosphorylation), and double phosphory-
lated (pY394+pY505). Two models have been proposed to122 Developmental Cell 47, 122–132, October 8, 2018 ª 2018 The Au
This is an open access article under the CC BY-NC-ND license (http://explain how TCR-pMHC binding initiates TCR signaling: (1) the
‘‘standby’’ model, where recognition of a pMHC does not in-
crease the active LCK population but causes redistribution of
active LCK or exposure of the ITAMs, which would result in the
initiation of TCR signaling (Nika et al., 2010); and (2) the ‘‘de
novo activation of LCK’’ model, where the active LCK population
is increased upon recognition of a cognate pMHC (Ballek et al.,
2015; Philipsen et al., 2017). Despite being crucial for LCK activ-
ity in cells, phosphorylation of tyrosine 394 in vitro results in only
a 2-fold increase of kinase activity of LCK (Hui and Vale, 2014;
Liaunardy-Jopeace et al., 2017). The ‘‘standby’’ model would
require a highly regulated mechanism to prevent phosphoryla-
tion of ITAMs in the absence of a cognate pMHC, and the ‘‘de
novo activation’’ model would require a mechanism that am-
plifies the impact of phosphorylating Y394. Although it has not
been reported until now, both models suggest some crosstalk
between LCK activation and its trafficking.
Following TCR signaling, T cells form immune synapses at the
interface with APCs, where a canonical synapse comprises three
concentric ringscalledsupramolecular activationcenters (SMAC):
central supramolecular activation centers (cSMACs), peripheral
supramolecular activation centers (pSMAC), and distal supramo-
lecular activation centers (dSMAC) (Monks et al., 1998). Although
the immune synapse is not enclosed in membranes, it still shows
specific localization and retention of LCK (Ehrlich et al., 2002).
In this study, we propose a trafficking model where the ciliary
UNC119A extracts and solubilizes LCK from membranes, which
is then released by the small GTPase ARL3-GTP at the immune
synapse where the ciliary ARL3 guanine nucleotide exchange
factor (GEF) ARL13B is localized. The activation of LCK by auto-
phosphorylation on tyrosine 394 disrupts the interaction of
UNC119A with LCK and thus traps active LCK on the destination
membrane. Our study describes a trafficking pathway for regula-
tion of the SFK, LCK, which has profound implications for how
T cells have co-opted the ciliary trafficking pathway to provide
spatial control of signaling at the immune synapse.
RESULTS
UNC119A Shows a Strong Specificity for LCK
UNC119A has been reported to interact with several myristoy-
lated SFKmembers (Cen et al., 2003), thus opening the question
of whether specificity could be achieved in SFK regulation bythor(s). Published by Elsevier Inc.
creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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UNC119A. We probed this specificity by measuring the binding
affinity constants of UNC119A to LCK or c-SRC using fluores-
cently labeled myristoylated N-terminal peptides in fluorescence
polarization experiments. The myristoylated LCK peptide bound
to UNC119A with more than 50-fold binding affinity compared to
c-SRC (ca 2 nM and 125 nM, respectively) (Figure 1A). This dem-
onstrates a clear specificity for UNC119A toward LCK. Further-
more, using recombinant GST-tagged UNC119A, we were able
to pull down LCK from Jurkat T-cell lysate (Figure 1B).
The GTP-bound form of the ciliary small G protein ARL3 (but
not its non-ciliary homolog ARL2) allosterically disrupts the
UNC119A interaction with myristoylated ciliary proteins by the
formation of a fast-dissociating ternary complex (Ismail et al.,
2012). We performed fluorescence polarization assays, as
above, in the presence of ARL3-GTP or ARL2-GTP, to probe
disruption of LCK/UNC119A. Only ARL3-GTP was able to
disrupt the interaction of the myristoylated LCK peptide with
UNC119A, shown by a decrease in the level of polarization (Fig-
ure 1C). The UNC119A-c-SRC complex was disrupted by both
ARL3-GTP and ARL2-GTP, supporting that LCK (but not
c-SRC) is a specific substrate for UNC119A (Figure 1D). To
confirm the allosteric mechanism of ARL3 displacing the myris-
toylated LCK peptide bound to UNC119A, we titrated in ARL3-
GTP and ARL2-GTP to a preformed LCK-UNC119A complex.
Only ARL3-GTP, and not ARL2-GTP, displaced the bound fluo-
rescently labeled LCK (Figure S1A, left). Nevertheless, ARL3-
GTP was not able to completely displace the bound LCK
peptide, which opposes a pure competitive model. This result
supports the formation of a ternary complex, where ARL3 binds
to UNC119A and not LCK, with reduced affinity to myristoylated
LCK (Figure S1A, right). Thus, we established that UNC119A in-
teracts with high affinity and specificity toward LCK and that this
complex is specifically disrupted by the ciliary ARL3-GTP,
potentially implicating LCK in a ciliary trafficking pathway.
LCK-UNC119A High-Affinity Binding Confers
Localization at the Immune Synapse
To gain atomic-level insight into the specificity of UNC119A to-
ward LCK, we solved the crystal structure of a myristoylatedFigure 1. High Affinity of Myristoylated LCK to UNC119A: Structural Ba
(A) Increasing concentrations of full-length UNC119A were titrated against 5-nM
and the resultant increase in fluorescence polarization was plotted against the co
as 2.2 ± 0.7 nM and 125 ± 69 nM, respectively.
(B)Western immunoblotwhere 30-mgGST-tagged full-lengthUNC119Awasused i
(C and D) Fluorescence polarization measurement, where 10-nM (C) or 0.5-uM (
0.5-mM c-SRC (Myr-GSNKSKPKDASQ) fluorescein-labeled myristoylated peptide
(E) Crystal structure of UNC119AD54 (gray) in a complex with a myristoylated L
indicating increasing B-factors.
(F) Surface representation of the UNC119A pocket (gray) enclosing the myristoyl
residues that can potentially clash with a bulky residue in LCK peptide (positions
(G) Sequence alignment of known ciliary UNC119A cargo proteins and examples
(H) 500-nM GppNHp-loaded ARL2 was added to a mixture of 100-nM UNC119A
LCK, and the resulting drop in fluorescence polarization was measured (the y a
polarization prior to the addition of ARL2-GppNHp) (the experiment was repeate
right: 2.64, 0.46, 3.13, 0.86, 2.42, 0.52, and 0.06).
(I) Jurkat T cells were nucleofected with either wild-type (LCKWTGFP) or low-affi
Jurkat T cells and Raji B cells incubated in SEE and CMAC (blue). Relative synap
LCKG4QGFP (n = 42) = 1.4. Mann-Whitney p% 0.0001. Scale bars, 5 mm. On the
inhibitor. DMSO-treated cells (n = 105) showed LCK LR = 1.54 and squarunkin A-tr
See also Figure S1.
124 Developmental Cell 47, 122–132, October 8, 2018LCK peptide in complex with UNC119A (54-240) at 2-A˚ resolution
(Figure1EandTableS1). Theasymmetricunit had threemolecules
of UNC119A in complex with the myristoylated LCK peptide. The
first four amino acids of the myristoylated LCK were well ordered
and superimposed well in the three complexes in the asymmetric
unit (FiguresS1BandS1C).Aminoacidsbeyond the fourth residue
were not visible in the electron density map, except in only one
complex molecule where amino acids 5 and 6 were visible (Fig-
ure S1B). UNC119A shows the expected beta sandwich immuno-
globulin conformation and the myristoyl group and the first three
aminoacids from theuniquedomainof LCKareburieddeep inside
the UNC119A hydrophobic pocket (Figures 1E and 1F). The myr-
istoylated peptide superimposes well with the reported crystal
structure of the ciliary myristoylated NPHP3 peptide in complex
withUNC119A (Jaiswal et al., 2016) (Figure S1D). Sequence align-
ment of reported myristoylated ciliary UNC119A interactors and
LCKdonot showany large residues at positions 3, 4, and5 (Zhang
et al., 2011) (Figure 1G). The structure shows limited space around
cysteine 3 and glycine 4,where large amino acidswould result in a
steric clash; however, there is more space around cysteine 5 (Fig-
ure 1F). To test the importance of having a small residue at these
positions, we took advantage of the fact that ARL2-GTP can
only displace lower binding affinity cargo bound to UNC119A.
We performed fluorescence polarization assays in which we
probed the ability of ARL2-GTP, at saturating concentrations, to
disrupt the interaction of UNC119A to different mutated LCKmyr-
istoylated peptideswith a large amino acid (glutamine) introduced
at positions 3, 4, or 5. The introduction of a glutamine residue at
these positions resulted in the ability of ARL2-GTP to disrupt the
UNC119A-peptide complex. To compare the impact of intro-
ducing a large amino acid between positions 3, 4, and 5, we
measured the ability of ARL2-GTP to disrupt the respective com-
plexesbymonitoring the fractions of the peptide that are released,
which are indicated by the drop in the polarization signal, under
similar conditions. Position 3 had the most impact, followed by
4 and then 5. Furthermore, to test the impact of the size of the
amino acid on the disruption of the complex, we repeated this
experiment with a smaller amino acid (asparagine), where we did
not observe any release by ARL2-GTP (Figure 1H).sis, ARL3-Specific Release, and Effect on Cellular Localization
fluorescein-labeled myristoylated LCK (black) or 0.5-mM c-SRC (red) peptides,
ncentration of UNC119A. Binding affinities for LCK and c-SRC were calculated
napull-downwith Jurkat T cells lysate. SN, supernatant; UNC, negative control.
D) full-length UNC119A was added to 5-nM LCK (Myr-GCGCSSHPED) (C) or
s followed by the addition of GppNHp-ARL2 (red) or -ARL3 (blue) as indicated.
CK peptide with the myristoyl group in green and the peptide in blue to red,
moiety (green) and LCK peptide (blue to red, increasing B-factors). UNC119A
3, 4, and 5) are shown in stick representation (gray).
of SRC family kinases (SFKs).
and 100-nM fluorescein-labeled N-terminal peptides of wild-type and mutant
xis represents the polarization signal normalized to the maximum increase in
d three times and standard deviations are presented as error bars, from left to
nity mutant LCK (LCKG4QGFP) (left). T:B cell conjugates were produced using
se localization (localization ratio, LR) of LCKWTGFP (n = 45) is 2.45, and that of
right side, T cells were treated with either DMSO or squarunkin A, a UNC119A
eated cells (n = 71) LCK LR = 0.94Mann-Whitney p% 0.0001. Scale bars, 5 mm.
Sequence alignment of the first six amino acids of all SFKs
shows LCK to be the only member that does not have a large
amino acid at positions 3, 4, and 5. To confirm our results, we
performed pull-down experiments, using GST-UNC119A as
bait, following in vitro myristoylation, by adding myristoyl-CoA
and the enzyme N-myristoyltransferase to the unique-SH3-
SH2 domains of HCK and FYN, in the presence and absence
of ARL2-GTP or ARL3-GTP. As expected, ARL2 was able to
disrupt the interaction ofHCKandFYN toUNC119A (Figure S1E).
Furthermore, HCK has an arginine residue at position 4 and small
amino acids at positions 3 and 5; thus, we mutated this residue
into the small amino acid glycine. Contrary to wild-typemyristoy-
lated HCK, which is released by both ARL2- and ARL3-GTP (Fig-
ure S1F, lanes 2 and 3), the myristoylated HCKR4G mutant was
only released by ARL3-GTP and not ARL2-GTP as in the case
of LCK, confirming our findings (Figure S1F, lanes 8 and 9).
From our experiments on LCK, we concluded that the absence
of large residues at positions 3, 4, and 5 is critical for a high-af-
finity binding interaction with UNC119A.
To investigate the significance of the affinity in the localization
and specific release of LCK by ARL3, we expressed the low-af-
finity mutant, LCKG4QGFP in Jurkat T cells and analyzed its
localization to a staphylococcal E enterotoxin (SEE)-induced
synapse. The LCKG4Q mutant is released by ARL3-GTP and
ARL2-GTP, due to weakening of the interaction with UNC119A
as seen from the structure (see above). We calculated the rela-
tive localization of LCKWTGFP and LCKG4QGFP to the immune
synapse by producing T-B cell conjugates, whereby the T cells
were nucleofected with the LCK-GFP constructs and B cells
incubated with the superantigen, SEE. The localization of the
GFP-tagged proteins to the immune synapse, relative to the
rest of the cell, was calculated using the ImageJ plug-in ‘‘im-
mune synapse measures,’’ and this localization was assigned
a localization ratio (LR) of 0, there being no localization (Cala-
bia-Linares et al., 2011). While LCKWTGFP shows an LR =
2.45, similar to that identified for endogenous LCK (Figure 3A),
LCKG4QGFP fails to localize efficiently to the synapse (LR =
1.4; Figure 1I).
To corroborate this finding, we analyzed the localization of
LCK to SEE-induced synapse in the presence of the selective
UNC119-cargo inhibitor squarunkin A, which blocks the
UNC119Amyristoyl binding pocket, thus inhibiting its interaction
with LCK (Mejuch et al., 2017). The localization of endogenous
LCK in the immune synapse was calculated relative to the rest
of the cell, as above. While LCK localization in the presence of
DMSO shows an LR = 1.54, relative localization in the presence
of squarunkin A was reduced to 0.94 (Figure 1I). These experi-
ments demonstrate the importance of the high-affinity binding
of LCK to UNC119A to enable correct localization and enrich-
ment at the immune synapse.
A Motif for UNC119A-Mediated Trafficking to the
Immune Synapse and Cilium
To investigate whether the structural requirement might enable
cargo prediction based on amino acid sequence, we searched
in the protein database for additional proteins with a myristoyla-
tion signal and without large residues at positions 3, 4, and 5.
Among the proteins identified were the ciliary proteins cystin,
NPHP3, and GNAT1, as well as the formin-like protein FMNL1,which was reported to localize at the immune synapse (Gomez
et al., 2007). FMNL1 was pulled down from Jurkat T cells by
GST-UNC119A, and specific treatment of the interaction with
ARL3-GTP released FMNL1 (Figure 2A). Fluorescence polariza-
tion experiments using N-terminal FMNL1 peptides confirmed
that FMNL1 interacts with UNC119A with a high affinity
compared to its homolog FMNL3 and is specifically released
from UNC119A by ARL3-GTP (Figures 2B–2D). Titrating ARL2
and ARL3 into a solution of UNC119A-FMNL1 peptide complex
resulted in FMNL1 release only in the case of ARL3 (Figure 2E).
These experiments suggest FMNL1 as a potential cargo protein
for UNC119A and further support the notion that cilia and im-
mune synapses share common features (de la Roche et al.,
2016). Thus, from our structural work, we were able to predict
a potential cargo of UNC119A and provide a basis for the spec-
ificity toward certain cargoes.Wedefined amotif, comprising the
myristoylation consensus sequence (PDOC00008-PROSITE) + a
small or medium size amino acid at positions 3, 4, and 5, for
UNC119A high-affinity binding that we name ‘‘UNC119A Spe-
cific Cargo’’ (USC) sequence.
Activation of ARL3 and Release of LCK at the Immune
Synapse
To investigate the activation and localization of ARL3 in com-
parison to LCK at the immune synapse, we used T-B cell
conjugates, whereby Jurkat T cells were added to Raji B cells
incubated with the superantigen, SEE, and the position of the
synapse identified by phosphorylated ZAP70 (pZAP70) (Fig-
ure 3A, green). ARL3 appeared to be dispersed throughout
the cell, whereas LCK was focused at the immune synapse. If
ARL3 is the release factor of UNC119A, it is likely that ARL3-
GTP is focused at the synapse to allow specific release. To
test this possibility, we expressed a constitutively active mutant
form of the protein (ARL3Q71L). When Jurkat T cells were nucle-
ofected with ARL3WTGFP, LCK localized to the immune syn-
apse (LR = 2), comparable to the localization of LCKWTGFP
(LR = 1.9; Figure 1I). However, expression of ARL3Q71L, which
is active throughout the cell, resulted in a significant reduction
in the localization of LCK to the immune synapse to LR = 1.09
(Mann-Whitney p = 0.0002) (Figures 3C and 3D). Thus, precise
activation of ARL3 at the immune synapse is crucial for release
of LCK. To measure the impact of the ARL3Q71L on T cell
signaling, we looked at expression of CD69 as a marker of
stimulation in Jurkat T cells, transfected with the same con-
structs and stimulated with anti-CD28 and CD3 antibodies
and analyzed using flow cytometry. Strikingly, expression of
ARL3Q71LGFP resulted in the increased expression of CD69
(Figure 3E). When CD69 expression in transfected cells was
normalized to 1 in GFP-transfected cells, ARL3WTGFP showed
no significant change in stimulation, while ARL3Q71LGFP stimu-
lation was increased by a factor of 2 (Figures 3E and S4A).
Interestingly, when the non-ciliary release factor, ARL2WTGFP,
and its constitutively active mutant, ARL2Q70LGFP, were trans-
fected into cells, we saw no alteration in T cell activation (Fig-
ures 3E and S4B). Thus, ARL3, previously thought to be a
specific cilia release factor, is clearly an essential component
of the regulation of the immune synapse, lending further sup-
port to the hypothesis that the immune synapse is a modified
cilium and that LCK trafficking is a central part of its function.Developmental Cell 47, 122–132, October 8, 2018 125
Figure 2. FMNL1 Is a High-Affinity Cargo for UNC119A
(A) Western immunoblot where 30-mg GST-tagged full-length UNC119A was used to pull down Jurkat lysate in the presence or absence of 30-mg ARL2GppNHp
or ARL3GppNHp.
(B) Full-length UNC119A was titrated into a solution of 0.2-mM fluorescein-labeled myristoylated FMNL1 (B) or FMNL3 (,) peptides. Binding affinities for FMNL1
and FMNL3 were calculated as 10.1 ± 3.5 nM and 856 ± 156 nM, respectively.
(C and D) Fluorescence polarization measurement where 0.5-mM full-length UNC119A was added to 0.5-mM fluorescein-labeled myristoylated FMNL1 (C, Myr-
GNAAGSAEQPAG) or FMNL3 (D, Myr-GNLESAEGVPGE) peptide followed by 5-mM GppNHp-loaded ARL2 or ARL3.
(E) GppNHp-loaded ARL2 and ARL3 were added in 2.5-mMsteps to a mixture of 0.5-mMfluorescein-labeledmyristoylated FMNL1 peptide and 0.5-mMUNC119A
as indicated.We then asked the question: what activates ARL3 at the im-
mune synapse? In cilia, ARL13B has been shown to function
as a GEF for ARL3 (Gotthardt et al., 2015). ARL13B is reported
to localize exclusively in cilia; however, lymphocytes are among
the few cell types that do not possess cilia. Endogenous ARL13B
and LCK were seen sparsely throughout the membrane of the
unstimulated cell (Figures 3A and 3F; SEE). ARL13B has not
previously been identified in non-ciliated cells, so we hypothe-
sized that T cells were co-opting this ciliary pathway at the im-
mune synapse. UNC119A has previously been shown to localize
to the immune synapse in Jurkat T cells (Gorska et al., 2004);126 Developmental Cell 47, 122–132, October 8, 2018however, ARL13B has not been studied in this system. Upon
its formation of the immune synapse, the immune synapse
shows a striking focusing of ARL13B that is similar to LCK (Fig-
ure 3F, red). To confirm our observation, we quantified the ratio
of fluorescence intensity at the immune synapse compared to
that in the rest of the cell membrane. While localization of
ARL3 showed a ratio of 0.2 that did not change after stimulation,
ARL13B and LCK showed ratios of 0.7 (ARL13B) and 0.8 (LCK) in
the unstimulated state, significantly increased (Mann-Whitney p
% 0.0001) in the presence of SEE to 2.1 (ARL13B) and 1.8 (LCK)
(Figure 3B). The specificity of ARL13B localization at the immune
(legend on next page)
Developmental Cell 47, 122–132, October 8, 2018 127
synapse shares a striking resemblance to that of ciliary localiza-
tion in retinal pigment epithelial (RPE) cells (Figures 3F and 3G),
again supporting the notion that cilia and immune synapses
share common features.
UNC119A Regulatory Arm Interacts with LCK Kinase
Domain
The myristoyl group is required for LCK to anchor to membranes
and mediates the interaction with UNC119A. Therefore,
UNC119A will not be able to interact with the lipid group unless
LCK is dissociated from the membrane. Given the high concen-
tration of membranes in the cell, an interaction interface addi-
tional to the myristoyl group would facilitate the interaction of
LCK with UNC119A and thus aid its extraction frommembranes.
To investigate the possibility of another interaction site between
UNC119A and LCK, we performed pull-down experiments using
full-length constructs of UNC119A and non-myristoylated LCK.
Indeed, recombinant non-myristoylated LCK was pulled down
using GST-UNC119A as bait (Figure 4A, lane 1). On further inves-
tigation, full-length UNC119A was able to interact, albeit weakly,
with only the kinase domain of LCK, as seen by pull-down exper-
iments using an LCK construct lacking the unique, SH3 and SH2
domains (Figure 4B, lane 1). LCK constructs comprising the
N-terminal domains and excluding the kinase domain were not
pulled down by UNC119A, both full-length and D54 (Figure S2A).
Rho guanosine nucleotide dissociation inhibitors (GDIs) are a
class of proteins that bind to lipid-modified Rho proteins. The
immunoglobulin-like b sandwich fold of Rho GDIs binds to the
lipid group of their cognate Rho proteins, whereas their N termi-
nus forms a regulatory arm that contacts the Rho switches
regions (Figure S2B). The Rho GDI regulatory arm senses the ac-
tivity status of their cognate Rho proteins (i.e., GTP- or GDP-
bound) and facilitates their extraction frommembranes (Hoffman
et al., 2000). Since Rho GDIs superimpose structurally well with
UNC119A D54, we hypothesized that UNC119A might act simi-
larly to Rho GDI (Figure S2B). However, the N-terminal first 54
amino acids of UNC119A were not included in the crystallized
construct as they hindered crystallization and so, to test if the
N terminus of UNC119A contacts LCK, we compared full-length
UNC119A and UNC119A-D54 in their ability to interact with non-
myristoylated LCK; only full-length showed binding (Figure 4A,
lanes 1 and 2). To further test this observation, we performed
the same experiment using the UNC119A paralog UNC119B,
which has a different N terminus. UNC119B did not interact
with non-myristoylated LCK (Figure 4A, lane 3). Additionally,Figure 3. ARL3-Specific Release Localizes LCK to the Immune Synaps
(A and F) T:B cell conjugates stained with anti ARL3, LCK, or ARL13B antibodies
(B) LR of ARL3, ARL13B, and LCK of conjugates from (A) and (F): ARL3 shows no l
LCK shows LR= 1.9 in the presence of SEE and 0.7 in its absence (n = 42; p% 0.00
(n = 16; p% 0.0001).
(C) ARL3WTGFP and the constitutively active ARL3Q71LGFP were nucleofected in
LCK antibodies.
(D) LR of LCK of conjugates from (C). ARL3WTGFP expression had little effect o
ARL3Q71LGFP-expressing cells showed LR of LCK = 1 (n = 16, p = 0.0002). Diffe
(E) CD69 expression was analyzed via flow cytometry for cells stimulated with a
ARL3Q71LGFP, ARL3-GFP, or GFP. ARL3Q71LGFP (p% 0.0001), ARL3WTGFP (p =
unpaired t test data.
(G) Ciliated RPE cell stained with anti ARL13B antibody.
Scale bars, 5 mm.
128 Developmental Cell 47, 122–132, October 8, 2018we tested the interaction of UNC119A with non-myristoylated
c-SRC; very little interaction was detected compared to that
of LCK as seen by pull-down experiments, confirming the
specificity of UNC119A toward LCK (Figure S2C, lanes 1
and 3). Neither showed pull-down with N-terminally truncated
UNC119A-D54 (Figure S2C, lanes 2 and 4).
A UNC119A mutation at glycine position 22 (G22V) has been
previously reported in a patient with idiopathic CD4 lymphopenia
(ICL) (Gorska and Alam, 2012). This mutation was reported to
disrupt the interaction of UNC119A with LCK, resulting in the
localization of the latter on the endosomes and reducing the
amount of LCK on the plasma membrane (Gorska and Alam,
2012). Since glycine 22 is present in the regulatory arm, we
wondered if this mutation abrogated the regulatory arm-LCK
interaction rather than the hydrophobic pocket interaction with
the myristoylated unique domain. Indeed, UNC119AG22V
interacted with the myristoyl group of LCK in a fluorescence po-
larization assay using fluorescently labeled myristoylated LCK
N-terminal peptide (Figure S2D). On carrying out a pull-down
experiment with UNC119AG22V-GST and full-length, non-myris-
toylated LCK, no binding was observed (Figure S2E, lanes 1
and 2). This result underscores the importance of the interaction
of the regulatory arm with the kinase domain. The localization of
LCK to the endosome in the G22V patient mutation supports our
proposed model in which UNC119A is recruited to LCK by
interaction with its kinase domain, where it extracts it from
membranes and deposits it at the desired destination (plasma
membrane).
Phosphorylation of LCK Y394 Inhibits Its Interaction
with UNC119A Regulatory Arm and Focuses It at the
Immune Synapse
Although activation of LCK by phosphorylation at tyrosine 394
results in a 2-fold increase in activity in vitro, in cells it has
been shown to be critical for the kinase activity (Hui and Vale,
2014; Liaunardy-Jopeace et al., 2017). Furthermore, it was
shown that phosphorylation of tyrosines 394 and 505 on LCK
regulates its clustering on plasma membrane (Rossy et al.,
2013). Activated LCK is localized at the immune synapse, not
the endosomes, as we confirm using anti pY394 antibody on
conjugates, in agreement with previous reports (Figure 4C).
Here, we investigated whether there is an additional layer of
regulation involved in the activation of LCK. We pre-incubated
LCK with ATP before performing pull-down experiments using
full-length UNC119A and non-myristoylated LCK. Strikingly,e
as indicated in the presence or absence of SEE.
ocalization to the synapse in the presence (LR = 0.3) or absence of SEE (n = 38).
01). ARL13B shows LR= 2 in the presence of SEE (n = 32) and 0.6 in its absence
to cells and T:B cell conjugates, in the presence of SEE, were stained with anti
n LR of LCK (n = 18) compared to cells not expressing ARL3WTGFP (LR = 2).
rences in LR were analyzed using the Mann-Whitney U test (B and D).
nti CD28 and CD3 antibodies and overexpressing ARL2-GFP, ARL2Q70LGFP,
0.004), ARL2WTGFP (p = 0.02), and ARL2Q70LGFP (p = 0.03) p values refer to
Figure 4. Phosphorylation Regulates the UNC119A N-Terminal Regulatory Arm Interaction with the Kinase Domain of LCK
(A and B) 30 mg of GST-tagged UNC119A-FL (A and B), UNC119A-D54 (A and B), and UNC119B-FL (A) were used to pull down 2 mg of non-myristoylated, full-
length LCK (A) or 12 mg of purified His-tagged LCK kinase domain (225–509) (B). The proteins were detected by immunoblotting using antibodies against
His and GST.
(legend continued on next page)
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the addition of ATP abolished the interaction, suggesting that a
phosphosite may regulate the interaction (Figure 4E, lanes 1
and 2). We then performed mass spectrometry analysis to iden-
tify which phosphosite results in inhibition of the interaction.
Mass spectrometry analysis showed several phosphorylated ty-
rosines upon incubation with ATP. To minimize the effect of non-
specific phosphorylation, we used the LCKK273R mutant, which
has significantly less kinase activity compared to wild-type
LCK (Figure S3B). During pull-down experiments using this
mutant in the absence of ATP, we observed a stronger interac-
tion of UNC119A with LCK, as indicated by a stronger LCK
band in the LCKK273R pull-down compared to that of the wild-
type protein (Figure S3C, lanes 1 and 2). Pre-incubation with
1 mM ATP for 15 min at room temperature inhibited the interac-
tion, thereby supporting the observation that autophosphoryla-
tion inhibits the interaction of LCK with UNC119A (Figure S3D,
left). Mass spectrometry analysis was carried out for the
K273R mutant under the same conditions that resulted in the
abrogation of interaction with UNC119A. The analysis showed
the phosphorylation of three tyrosine residues: Y181, Y394,
and Y489 (Figure S3D, right). We mutated each of these tyrosine
residues as well as several others predicted to be phosphoryla-
tion sites to phenylalanine and repeated the pull-down experi-
ments to screen for a mutant that showed strong binding to
UNC119A despite being phosphorylated on other sites. The
mutant residue in this case would likely have a role in regulating
the interaction between UNC119A and LCK. All mutants were
highly phosphorylated, as seen by anti-phosphotyrosine anti-
body staining; however, LCKY394F showed the strongest binding
compared to LCKWT, LCKK273R, and the other mutants (Figures
4F [lane 2], S3E, and S3F). Incubation of LCKY394F with ATP
did not abolish the interaction with UNC119A compared to the
significantly less active K273R mutant (Figure 4G, lanes 2
and 4). We therefore conclude that it is the phosphorylation of
tyrosine 394 that inhibits the interaction of UNC119A regulatory
arm with the kinase domain of LCK.
If this additional interaction is indeed inhibited by the phos-
phorylation of tyrosine 394, we wanted to investigate whether
this UNC119A interaction had an effect on the kinase activity
of LCK, through tracking its autophosphorylation over time. We
incubated LCKK273R, to start with an unphosphorylated LCK
population, with ATP following in vitromyristoylation in the pres-
ence of full-length UNC119A or UNC119A-D54. LCKK273R incu-(C) Jurkat T cells were nucleofected with LCK394FGFP, and SEE-induced conj
LR = 3.89, whereas LR of LCK394F = 0.72 (p < 0.0001). Scale bars, 5 mm.
(D) In the presence of the LCK inhibitor (CAS 213743-31-8), LCK failed to focus at t
(LR = 1.68). Mann-Whitney p% 0.0001.
(E and F) 30 mg of full-length UNC119A-GST was used to pull down 2 mg of non-m
3 mg of non-myristoylated full-length LCKWT, LCKY394F, LCKY505F, and LCKY
(G) 60 mg of full-length UNC119A-GST was used to pull down 12 mg of purified n
1-mM ATP for 15 min at room temperature.
(H) 6 mg of purified non-myristoylated LCKK273R was used for in vitromyristoylat
(right) before incubating with 1-mM ATP. Autophosphorylation of LCK was monit
detected using antibodies as indicated on the figures.
(I) Left: Myristoylated LCK is extracted from membranes by UNC119A through
myristoyl group binding. Solubilized LCK can then be transported in the cytosol. Lo
ARL3. LCK released by ARL3-GTP can then anchor to the plasma membran
(i.e., activation of LCK). (I) Right: A model of how farnesylated ciliary INPP5E is s
See also Figures S2–S4.
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tion as seen upon staining with an anti-phosphotyrosine
antibody, whereas incubation with full-length UNC119A showed
reduced autophosphorylation (Figure 4H). We therefore
conclude that UNC119A interacts with LCK and blocks its
autophosphorylation.
To further investigate the effects of LCK phosphorylation at
Y394, we produced a GFP-tagged version of LCKY394F,
LCKY394FGFP and followed its localization upon stimulation of
the immune synapse. While LCKWT, as discussed above, local-
izes to the synapse within 5 min of synapse induction and with
an LR= 2.45 (Figure 4C), LCKY394FGFP fails to localize to the syn-
apse, producing an LR = 0.72. In comparison, active LCK phos-
phorylated at Y394 and has an LR = 3.89, significantly higher
than both LCKWT and LCKY394F (p < 0.0001). Since LCKY394 un-
dergoes trans-autophosphorylation, we wanted to investigate
the effect of inhibiting LCK kinase activity on its enrichment at
the immune synapse. For this, we followed the localization of
LCK upon the formation of immune synapse in the presence of
the selective LCK inhibitor (CAS 213743-31-8) or DMSO control
(LR = 1.68). In the presence of the inhibitor, LCK failed to focus at
the immune synapse (LR = 1.05). (Figure 4D). These results pro-
vide a strong indication that LCK phosphorylation and activity is
required for its enrichment at the immune synapse, drawing
strong links between activity phosphorylation and localization.
DISCUSSION
LCK associates with CD4 on intracellular membranes within
10 min after synthesis and is transported to the plasma mem-
brane by vesicular trafficking (Bijlmakers and Marsh, 1999).
However, when cells were treated with brefeldin A, a fraction
of LCK was still able to localize at the plasma membrane, and
the authors suggested another direct route beside vesicle traf-
ficking (Bijlmakers and Marsh, 1999). Furthermore, using sin-
gle-molecule fluorescence microscopy, it was shown that a
non-vesicular cytosolic fraction of LCK traffics directly to the
plasma membrane (Zimmermann et al., 2010). These observa-
tions suggest another cytosolic route of transport of LCK to the
plasma membrane. Our proposed model would represent a
fast route of targeting compared to vesicle trafficking. In cyto-
toxic T lymphocytes (CTLs), the cSMAC forms in two stages: a
fast initial stage, which was proposed to take place via lateralugates were stained with anti pY394 LCK antibody (red). pY394LCK showed
he immune synapse (LR = 1.05). This was compared to a DMSO-treated control
yristoylated, active LCK that was incubated with 1 mM ATP for 6 hr on ice (E) or
394+505F (F). The white lines indicate irrelevant lanes that were spliced.
on-myristoylated LCKK273R and LCKY394F before and after incubation with
ion in the presence of 30 mg of GST-tagged UNC119-D54 (left) or UNC119A-FL
ored by taking samples at 0, 5, 10, 15, and 30 min. Proteins on (E) to (H) were
a regulatory-arm kinase domain interaction as well as hydrophobic pocket-
calization of GEFs such as ARL13B at the immune synapse drives activation of
e; the reverse process is inhibited by phosphorylation of LCK tyrosine 394
orted into the cilium using PDE6D (Fansa et al., 2016).
diffusion, followed by vesicular trafficking (Ritter et al., 2015). Our
model might represent an initial fast route to the immune syn-
apse. Another possibility would be UNC119A facilitating the
deposition of LCK from endosomal vesicles to the immune syn-
apse, as was previously suggested (Gorska et al., 2009). A role of
UNC119A in targeting LCK from both plasmamembrane and en-
dosome cannot be excluded, especially based on the co-locali-
zation of UNC119A and LCK at both the plasma membrane and
endosomes (Figures 4I and S4C).
LCK undergoes co- and post-translational modifications
including myristoylation and palmitoylation, which are critical
for the localization of LCK on plasma membranes and RAB11-
positive endosomes (Gorska et al., 2009; Zlatkine et al., 1997).
Palmitoyl acyltransferase DHHC21 has specificity for LCK and
is localized on the plasma membrane (Akimzhanov and Boehn-
ing, 2015). This supports our model, as it would result in the
long-term entrapment of myristoylated and palmitoylated LCK
on the membrane. It will be interesting to investigate the palmi-
toylation-depalmitoylation cycle of LCK in the context of the
model we are proposing and whether LCK is maintained at the
immune synapse by spatial cycles of solubilization, release,
and palmitoylation at the plasma membrane.
Cilia are found on almost all cell types, a rare exception being
T cells (Goetz and Anderson, 2010). Nevertheless, similarities
between the cilium and immune synapse have recently become
an exciting and growing field (de la Roche et al., 2016). For the
cilium to concentrate lipid-modified proteins, it uses UNC119A,
UNC119B, and PDE6D (Figure 4I). Our results support the notion
that the cilia and immune synapses share common mechanistic
features.
All proteins involved in the proposed model are involved in cil-
iopathies, and of particular interest is UNC119A, which has been
reported to be involved in a ciliopathy-related, cone-rod dystro-
phy (Kobayashi et al., 2000). Interestingly, UNC119A has also
been reported to be involved in ICL, an immunodeficiency disor-
der, providing an interesting link between the fields of immu-
nology and cilia research (Gorska and Alam, 2012). Our current
study will provide possible links between immune pathologies
and ciliopathies and will open the door for further investigations.STAR+METHODS
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Antibodies
anti-His monoclonal Takara/Clontech Cat#631212; RRID: AB_2721905
anti-GST polyclonal GE Healthcare, Cat#27-4577-01V; RRID: AB_771432
anti-LCK Sigma-Aldrich Cat#HPA003494; RRID: AB_1852751
anti-LCK pY505 BD Biosciences Cat#558552; RRID: AB_397084
anti-LCK pY394 Abcam Cat#ab201567
anti-FMNL1 Bethyl Laboratories Cat#A304-869A; RRID: AB_2621064
anti-Phospho-ZAP70 (Y493) R&D Systems Cat#MAB7694
IRDye 680RD Donkey Anti-Rabbit IgG (H+L) Li-Cor Cat#926-68073; RRID: AB_10954442
IRDye 800CW Donkey Anti-Mouse IgG (H+L) Li-Cor Cat#926-32212; RRID: AB_621847
IRDye 680RD Donkey Anti-Goat IgG (H+L) Li-Cor Cat# 926-68076; RRID: AB_10956590
CD69 monoclonal antibody (CH/4), APC ThermoFisher Cat#MHCD6905; RRID: AB_10372807
Bacterial and Virus Strains
BL21(DE3)CodonPlus Agilent Technologies 230245
Chemicals, Peptides, and Recombinant Proteins
full length c-SRC Merck/Millipore 14-326
Myr-GCGCSSHPED-OH JPT peptide technologies N/A
Myr-GCGCSSHPED-K(5/6-Fluorescein)-amide Alta Bioscience, University of Birmingham N/A
Myr-GQGCSSHPED-K(5/6-Fluorescein)-amide Alta Bioscience, University of Birmingham N/A
Myr-GCQCSSHPED-K(5/6-Fluorescein)-amide Alta Bioscience, University of Birmingham N/A
Myr-GCGQSSHPED-K(5/6-Fluorescein)-amide Alta Bioscience, University of Birmingham N/A
Myr-GNGCSSHPED-K(5/6-Fluorescein)-amide Alta Bioscience, University of Birmingham N/A
Myr-GCNCSSHPED-K(5/6-Fluorescein)-amide Alta Bioscience, University of Birmingham N/A
Myr-GCGNSSHPED-K(5/6-Fluorescein)-amide Alta Bioscience, University of Birmingham N/A
Myr-GNAAGSAEQPAG-Fluorescin-amide Alta Bioscience, University of Birmingham N/A
Myr-GNLESAEGVPGE-Fluorescin-amide Alta Bioscience, University of Birmingham N/A
Critical Commercial Assays
ProFluor Src-Family Kinase Assay Promega V1270
Deposited Data
UNC119A-LCK structure RCSB 6H6A
Experimental Models: Cell Lines
Jurkat, clone E6-1 cells ATCC TIB-152
Raji B cells DSMZ ACC 319
RPE ATCC CRL-4000
Recombinant DNA
pET20b-ARL3 This paper N/A
pET20b-ARL3 This paper N/A
pET20b-LCK This paper N/A
pET20b-LCK(SH3)( 1-121) This paper N/A
pET20b-LCK(SH3-SH2)( 1-226) This paper N/A
pET20b-HCK(SH3-SH2) This paper N/A
pET20b-Fyn(SH3-SH2) This paper N/A
pGEX-4T-1-UNC119A This paper N/A
pGEX-4T-1-UNC119B This paper N/A
pGEX-4T-1-UNC119A(54-240) This paper N/A
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Grafit analysis software Erithacus Software http://www.erithacus.com/grafit/
Pymol Schro¨dinger, LLC https://pymol.org/2/
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture
Jurkat T-cells (Clone E6-1, ATCC,TIB-152, human, male) and Raji B cells (DSMZ, ACC 319, human, male) were maintained in RPMI
medium (Thermo Fisher Scientific) with 10% Fetal Calf Serum (FCS). Retinal Pigmented Epithelial (RPE, ATCC, CRL-4000, human,
female) cells were maintained and serum starved in DMEM:F12(Thermo Fisher Scientific). All cell lines were grown at 37C and
5% CO2.
METHOD DETAILS
Plasmid and Proteins
Full length ARL3 and ARL2 were cloned into pET20b (Novagen) with a C-terminal histidine tag. UNC119A, full length, UNC119A-D54
(54-240), and UNC119B, full length were cloned into pGEX-4T-1 (GE Healthcare) with an N-terminal GST tag and purified using a
GSTrap HP column (GE Healthcare) followed by size exclusion chromatography. LCK SH3 (residues 1-121), SH3-SH2 (residues
1-226), c-SRC and HCK were cloned in pET20b with C-terminal histidine tags. All histidine tagged constructs were purified using
a two-step purification protocol including a nickel affinity His-Trap HP (GE Healthcare) chromatography followed by a size exclusion
chromatography. Full-length LCKwas cloned in pET20b, expressed in BL21(DE3)CodonPlus E. coli cells. Purification was carried out
in the same manner as for the shorter constructs, with the addition of 5% glycerol to all purification buffers and increasing the
concentration to 20% for storage. Non-myristoylated, full length c-SRC with an N-terminal 6x His-tag was purchased from
Merck/Millipore (catalogue number 14-326). The LCK myristoylated peptide (Myr-GCGCSSHPED-OH) was purchased from JPT
peptide technologies. pET28(NMT) was a gift from Jim Brannigan.
Antibodies and Westerns
Antibodies used in this study: anti-Hismonoclonal (Takara/Clontech, 631212), anti-GST polyclonal (GEHealthcare, 27457701V), anti-
LCK (Sigma-Aldrich, HPA003494), anti-LCK pY505 (BD Biosciences, 558552), anti-LCK pY394 (Abcam, ab201567). Western blots
were imaged using film or using Li-Cor secondary antibodies and visualised on a Li-Cor Odyssey CLX imaging system.
Nucleotide Exchange
400 mM ARL2 or ARL3 was incubated overnight at 15C with 2 mM of the GTP analogue GppNHp (Jena Bioscience Gmbh) and 69
units of Alkaline phosphatase (Roche). Unbound nucleotideswere removed by size exclusion chromatography, using a Superdex 200
Increase column (GE Healthcare). HPLC (UltiMate 3000, ThermoFisher Scientific) analysis using C18 columns was used to determine
the concentration of loaded ARL-GppNHp.
Myristoylation
Myristoylation of LCK, c-SRC and HCK was done in vitro using recombinant N-myristoyl transferase (NMT) and myristoyl-CoA
(Padovani et al., 2013).
Pull-Down Assays with Recombinant Proteins
Pull-downs were typically carried out using 30 mg of GST-tagged UNC119A and 12 mg of LCK in a buffer containing 50mMTris (pH 8),
1 mMMgCl2, 1 mM DTT, 0.02% Triton X-100. Reactions including in vitromyristoylation also contained 2.5 mMN-myristoyltransfer-
ase (NMT) and 100 mM Myristoyl-CoA. Reactions were incubated at room temperature for 3 hours before the addition ofe2 Developmental Cell 47, 122–132.e1–e4, October 8, 2018
ARL2-GppNHp or ARL3-GppNHp with further incubation at room temperature for 10 minutes. Reactions were then added to Gluta-
thione sepharose 4 FF beads (GE Healthcare) and incubated at room temperature for 20 minutes. Beads were washed 5 times in GF
buffer (25 mM Tris (pH 7.5), 200 mM NaCl, 2 mM DTT, and finally proteins were eluted for 10 minutes using GF buffer containing
20 mM Glutathione.
In Vitro Fluorescence Measurements
Fluorescence polarisation measurements were done in a buffer containing 25 mM Tris (pH 7.5), 150 mM NaCl, 5 mM MgCl2 2 mM
DTT. Data were recorded using a QuantaMaster fluorometer (Photon Technology International) with excitation at 490 nm and emis-
sion at 520 nm for fluorescein-labelled peptides. Data analysis was done using Grafit 5.0 program (Erithracus software, Horley UK).
Fluorescein-labelled LCK wild-type peptide (Myr-GCGCSSHPED-K(5/6-Fluorescein)-amide) and its mutant versions (C3Q, C3N,
G4Q, G4N, C5Q, and C5N), as well as FMNL1 (Myr-GNAAGSAEQPAG) and FMNL3 (Myr-GNLESAEGVPGE) peptides were pur-
chased from Alta Bioscience, University of Birmingham.
Crystallization and Structure Solution
A solution of UNC119A-D54 at a concentration of 746 mM in a buffer containing 25 mM Tris (pH 7.5), 150 mM NaCl, 2 mM DTT was
mixed with pure myristoylated LCK peptide (Myr-GCGCSSHPED-OH ) at a 1:1 molar ratio. Crystals appeared in a Qiagen suite PEG
(20%w/v PEG 3350, 200mMKH2PO4) at 4
C. Crystals were flash frozen in a solution containing themother liquor with 25% glycerol.
The data were integrated with automated XDS and scaled with the CCP4 suite. Molecular replacement was done with the program
Molrep using UNC119A (PDB code 3RBQ) as a search model. Refinement was done by the program Refmac 5 and manual building.
Kinase Assay
Kinase activity of wild-type and mutant versions of LCK was measured using the ProFluor Src-Family Kinase Assay kit (Promega),
as per the manufacturer’s instructions and measured using a Tecan Safire 2 multi-mode plate reader (ThermoFisher).
Nucleofection
Jurkat T-cells were nucleofected with ARL3, ARL13B andmutant expression constructs in EGFP N1 using the Amaxa Nucleofector II
Kit V (Lonza, Switzerland) as per the instruction manual.
LCK Inhibitor Treatment
Jurkat T-cells were treated with LCK Inhibitor (sc-204052, Santa Cruz Biotechnology, USA) at 0.5 mM in complete medium.
UNC119 Inhibitor Treatment
Jurkat T-cells were treated with 2 mM Squarunkin A (GLXC-10229, Glixx Labs, USA) in complete medium.
Conjugate Formation
Raji B cells were incubated at 106 cells/ml for 1 hour in RPMI plus 10 mM CMAC (Life Technologies, USA) and 1 mg Staphylococcal
E Enterotoxin (SEE) (Toxin Technologies, USA) for 1 hour at 37C before washing 3 times in complete medium. Jurkat T-cells were
then introduced at a ratio of 1:1 and plated on Poly-L-Lysine (Sigma, UK) coated coverslips (approx. 105 per coverslip) and incubated
at 37C for 10 minutes before fixing with ice-cold methanol for 2 minutes followed by several washes in PBS before preparation for
immunofluorescence.
Immunofluorescence
Fixed conjugates were incubated in 5% Donkey serum (Sigma, UK) and 0.01% Triton X-100 for 1 hour at room temperature and
incubated in primary antibody overnight. The following antibodies were used: anti-Phospho-ZAP70 (Y493) (R&D Systems, USA
MAB7694), anti-LCK (Sigma, HPA003494), anti-LCK pY394 (Abcam, ab201567), anti-ARL3 (Proteintech, UK 10961-1-AP), anti-
ARL13B (Proteintech, 17711-1-AP), anti-GFP488 (Biolegend, FM264G). RPE cells were fixed in Methanol and immunofluorescence
staining carried out as described above. Cilia were identified using anti-ARL13B and anti-g Tubulin (Sigma, T5192).
Microscopy
Optical sectionswere taken using the LSM880 Airyscan or LSM710 (Zeiss, Germany) and analysed following deconvolution using Fiji
(ImageJ). Localisation of proteins to the immune synapse were analysed using the Fiji Plug in Synapse Measures as described by
(Calabia-Linares et al., 2011).
Flow Cytometry
Nucleofected Jurkat T-cells were stimulated after 24 hours using an anti-CD3 (UCH-T1, Abcam, ab22) coated 96 well plate and sol-
uble anti-CD28 (BD, Pharmingen, USA, 555726). Cells were stimulated for 4 hours and then analysed using flow cytometry to identify
CD69 expression (CD69APC, Invitrogen, USA, MHCD6905). Expression of GFP and APC were measured using the Attune NxT
(Thermo Fisher Scientific) and analysed using FlowJo software 10.4.2. The percentage of cells becoming stimulated were calculated
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QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification of Proteins to the Immune Synapse
The localisation of proteins to the immune synapse, relative to the rest of the cell was calculated using the ImageJ plug in ‘immune
synapse measures’ and this localisation assigned a localisation ratio (LR), 0 being no localisation. All statistics and n values are
included in figure legends.
T-Cell Stimulation
T-cell stimulationwas quantified using flow cytometry to identify CD69 expression (CD69APC, Invitrogen, USA,MHCD6905). Expres-
sion of GFP andAPCweremeasured using the AttuneNxT (Thermo Fisher Scientific) and analysed using FlowJo software 10.4.2. The
percentage of cells becoming stimulatedwere calculated and normalised by dividing the percentage of treated cells by that of control
cells. Statistics and n values are included in the relevant figure legend.
Binding Affinities
Binding affinities were calculated by fitting the titation data to a quadratic equation using Grafit analysis software (Erithacus
Software). Dissociation constants are provided in the figure legends.
DATA AND SOFTWARE AVAILABILITY
The accession number for the UNC119A-LCK crystal structure reported in this paper is PDB: 6H6A.e4 Developmental Cell 47, 122–132.e1–e4, October 8, 2018
